Further, we propose α-MSH-induced CRE-driven reporter gene activity be the preferred high-throughput screen to discover potential safe and effective anti-MC4R signaling therapeutics targeting obesity. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.